{"title":"Criteria to Assess Whether a Medicine Should Be Entered in the List of Reimbursable Treatments","authors":"","doi":"10.1093/grurint/ikad044","DOIUrl":null,"url":null,"abstract":"Sialanar","PeriodicalId":432164,"journal":{"name":"GRUR International","volume":"38 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GRUR International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/grurint/ikad044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
